ELK-003

N/A

Report date: 2025/04/14 16:30:17

Base Information

Drug NameELK-003
Drug Alias NameAmniotic Fluid SecretomeELK-003
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationEpidermolysis Bullosa, JunctionalEpidermolysis Bullosa Dystrophica +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesChile
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEliksa Therapeutics IncFundación DEBRA Chile, Niños Piel de Cristal
China Registration ClassN/A

Develop Information

Active CompaniesEliksa Therapeutics IncFundación DEBRA Chile, Niños Piel de Cristal
Inactive CompaniesN/A
Active IndicationsInflammationEpidermolysis Bullosa, JunctionalEpidermolysis Bullosa Dystrophica +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A